US Stock MarketDetailed Quotes

RUBY Rubius Therapeutics

Watchlist
  • 0.057000
  • 0.0000000.00%
15min DelayClose Dec 29 16:00 ET
5.16MMarket Cap-0.03P/E (TTM)

About Rubius Therapeutics Company

Rubius Therapeutics Inc develops red cell therapeutics (RCTs) for the treatment of patients with rare diseases, cancer, and autoimmune diseases.

Company Profile

SymbolRUBY
Company NameRubius Therapeutics
Issue Price23.00
CEOMs. Dannielle Appelhans
MarketPink Market
Employees6
Fiscal Year Ends12-31

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Pablo J. Cagnoni, M.D.
  • Chairman of the Board
  • --
  • Sir Jonathan Richard Symonds CBE
  • Independent Director
  • --
  • Dr. Catherine A. Sohn, Pharm.D.
  • Independent Director
  • --

Trending Stocks

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Chinese stocks keep rallying: What will drive the next move?
🎙️Discussion 1. With the government's emphasis on technological innovation and sustainability, which industry sectors do you believe hold t Show More